Skip to main content

REACH 30/30 - 14 February 2023

Tue, Feb 14, 2023
Scientist in lab
©2024 Keller and Heckman LLP

Keller and Heckman LLP will present a webinar on the European Union’s Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) Regulation as part of the REACH 30/30 webinar series. REACH 30/30 complimentary webinars are presented by Keller and Heckman LLP’s Chemical Control attorneys and scientists located in Brussels, Belgium. This REACH 30/30 webinar is presented by Partner Ales Bartl and Scientist Javier Jaramillo García.

REACH impacts substances manufactured in, or placed on, the European Economic Area (EEA) market (the 27 EU member states plus Iceland, Liechtenstein, and Norway). Its broad scope affects not only chemical companies, but the entire supply chain, and not only industrial chemicals, but also ingredients used in food packaging and cosmetics.

As a leader in the use of interdisciplinary approaches, Keller and Heckman attorneys and scientists understand the complex interaction between product-specific legislation and REACH. We have counseled clients in chemical, fuel, food, food packaging, cosmetics, soap and detergent, and other affected industries on REACH-related matters. We are at the forefront of helping clients adapt to and comply with the complex requirements from our offices around the world, Serving Business Through Law and Science®.

Topic: PFAS Restriction Proposal Under REACH

Due to the release on 7 February 2023 of the Member States' proposal to restrict the manufacture, sale, and use of per- and poly-fluoroalkyl substances (PFAS) under REACH, we hosted this REACH 30/30 on Tuesday, 14 February 2023, to provide you with our summary of this proposal and how it could affect your business.

Webinar Details
: Tuesday, 14 February 2023
Time: 10:00 - 10:30 AM ET | 4:00 - 4:30 PM CET
Location: Your Office!
Cost: Complimentary
This webinar will offer the option for live captioning, provided by Zoom.

Click below to view a recording of the February 2023 webinar.